See more : Chainqui Construction Development Co., Ltd. (2509.TW) Income Statement Analysis – Financial Results
Complete financial analysis of NOF Corporation (NOFCF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NOF Corporation, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Brompton Lifeco Split Corp. (LCS.TO) Income Statement Analysis – Financial Results
- CT Real Estate Investment Trust (CRT-UN.TO) Income Statement Analysis – Financial Results
- Adbri Limited (ABC.AX) Income Statement Analysis – Financial Results
- Starboard Value Acquisition Corp. (SVACU) Income Statement Analysis – Financial Results
- Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (GEDSF) Income Statement Analysis – Financial Results
NOF Corporation (NOFCF)
About NOF Corporation
NOF Corporation manufactures chemicals in Japan. The company operates through Functional Chemicals, Life Science, and Explosive & Propulsion segments. The Functional Chemicals segment offers fatty acids and derivatives, surfactants, ethylene oxide and propylene oxide derivatives, organic peroxides, functional polymers, functional films, petrochemical products, and electronic materials, as well as special corrosion prevention agents. The Life Science segment provides edible oils, functional foods, activated PEG, functional lipids, surfactants for drugs, biocompatible materials, plant-derived ingredients, and MPC polymer/monomer. The Explosive & Propulsion segment offers industrial explosives, solid propellants, pyrotechnic devices, gun propellant/rocket propellant, guided missile assemblies, anti-freezing agents, and temperature and sterilization indicators. It is also involved in logistics, insurance agency, and real estate businesses. The company was founded in 1937 and is headquartered in Tokyo, Japan.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 222.25B | 217.71B | 192.64B | 172.65B | 180.92B | 189.15B | 179.94B | 174.06B | 170.46B | 167.70B | 160.96B | 148.86B | 152.36B | 154.12B | 143.38B | 150.32B | 159.05B | 150.21B | 143.16B | 133.68B |
| Cost of Revenue | 142.76B | 141.77B | 123.71B | 115.26B | 122.31B | 128.26B | 122.31B | 118.26B | 119.97B | 120.44B | 116.74B | 108.59B | 113.11B | 114.76B | 109.72B | 117.88B | 120.85B | 110.31B | 104.08B | 98.62B |
| Gross Profit | 79.49B | 75.94B | 68.93B | 57.39B | 58.60B | 60.89B | 57.63B | 55.80B | 50.49B | 47.26B | 44.22B | 40.27B | 39.26B | 39.37B | 33.66B | 32.44B | 38.20B | 39.90B | 39.08B | 35.06B |
| Gross Profit Ratio | 35.77% | 34.88% | 35.78% | 33.24% | 32.39% | 32.19% | 32.03% | 32.06% | 29.62% | 28.18% | 27.47% | 27.05% | 25.76% | 25.54% | 23.48% | 21.58% | 24.02% | 26.56% | 27.30% | 26.22% |
| Research & Development | 0.00 | 6.57B | 6.11B | 5.76B | 6.15B | 6.41B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 23.68B | 22.27B | 20.55B | 21.10B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 5.94B | 5.88B | 5.36B | 5.45B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 37.35B | 29.62B | 28.15B | 25.91B | 26.55B | 27.01B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 586.00M | 433.00M | 1.09B | 724.00M | 541.00M | 705.00M | 495.00M | 561.00M | 741.00M | 614.00M | 395.00M | 559.00M | 1.02B | 739.00M | 1.11B | 673.00M | 521.00M | 598.00M | 737.00M |
| Operating Expenses | 37.35B | 35.32B | 33.33B | 30.78B | 31.73B | 32.45B | 31.81B | 31.46B | 31.12B | 30.17B | 28.87B | 27.93B | 28.09B | 28.80B | 28.05B | 28.82B | 28.19B | 28.30B | 27.94B | 26.75B |
| Cost & Expenses | 180.11B | 177.08B | 157.05B | 146.04B | 154.04B | 160.71B | 154.12B | 149.72B | 151.10B | 150.61B | 145.61B | 136.52B | 141.20B | 143.55B | 137.77B | 146.70B | 149.04B | 138.61B | 132.01B | 125.38B |
| Interest Income | 358.00M | 174.00M | 137.00M | 83.00M | 96.00M | 113.00M | 128.00M | 131.00M | 169.00M | 161.00M | 130.00M | 52.00M | 69.00M | 48.00M | 38.00M | 63.00M | 155.00M | 149.00M | 106.00M | 112.00M |
| Interest Expense | 129.00M | 80.00M | 60.00M | 61.00M | 69.00M | 80.00M | 80.00M | 70.00M | 84.00M | 93.00M | 89.00M | 123.00M | 247.00M | 253.00M | 330.00M | 443.00M | 452.00M | 407.00M | 434.00M | 587.00M |
| Depreciation & Amortization | 6.94B | 6.36B | 6.36B | 5.91B | 5.55B | 5.30B | 5.04B | 4.91B | 4.77B | 4.68B | 5.70B | 5.87B | 6.45B | 7.30B | 7.65B | 7.56B | 6.99B | 5.80B | 5.41B | 5.38B |
| EBITDA | 55.54B | 54.48B | 43.95B | 34.67B | 35.61B | 35.83B | 33.49B | 29.56B | 24.67B | 22.45B | 20.54B | 18.98B | 17.63B | 18.17B | 13.72B | 12.06B | 17.38B | 18.99B | 17.25B | 20.35B |
| EBITDA Ratio | 24.99% | 22.84% | 22.71% | 20.08% | 18.98% | 18.68% | 18.10% | 17.28% | 14.97% | 14.24% | 14.60% | 13.25% | 12.31% | 12.19% | 9.74% | 8.14% | 11.12% | 12.13% | 12.24% | 10.87% |
| Operating Income | 42.14B | 40.62B | 35.60B | 26.60B | 26.87B | 28.44B | 25.82B | 24.34B | 19.37B | 17.09B | 15.35B | 12.34B | 11.16B | 10.57B | 5.61B | 3.62B | 10.01B | 11.60B | 11.14B | 8.31B |
| Operating Income Ratio | 18.96% | 18.66% | 18.48% | 15.41% | 14.85% | 15.04% | 14.35% | 13.98% | 11.36% | 10.19% | 9.54% | 8.29% | 7.33% | 6.86% | 3.91% | 2.41% | 6.29% | 7.72% | 7.78% | 6.21% |
| Total Other Income/Expenses | 6.33B | 7.42B | 2.38B | 7.51B | 3.36B | 2.27B | 2.69B | 389.00M | 223.00M | 593.00M | -592.00M | 652.00M | -226.00M | 42.00M | 136.00M | 430.00M | -72.00M | 1.19B | 267.00M | 6.07B |
| Income Before Tax | 48.47B | 48.04B | 37.98B | 34.11B | 30.24B | 30.71B | 28.50B | 24.73B | 19.59B | 17.68B | 14.76B | 12.99B | 10.94B | 10.61B | 5.75B | 4.05B | 9.93B | 12.79B | 11.41B | 14.38B |
| Income Before Tax Ratio | 21.81% | 22.07% | 19.71% | 19.76% | 16.71% | 16.24% | 15.84% | 14.21% | 11.49% | 10.54% | 9.17% | 8.73% | 7.18% | 6.88% | 4.01% | 2.70% | 6.25% | 8.51% | 7.97% | 10.76% |
| Income Tax Expense | 14.41B | 14.03B | 11.26B | 10.79B | 9.07B | 8.63B | 8.62B | 7.12B | 5.98B | 5.94B | 5.01B | 4.18B | 3.55B | 3.63B | 2.01B | 1.49B | 3.11B | 5.29B | 4.77B | 6.00B |
| Net Income | 33.99B | 33.97B | 26.69B | 23.30B | 21.14B | 22.03B | 19.91B | 17.59B | 13.59B | 11.70B | 9.74B | 8.78B | 7.32B | 6.89B | 3.50B | 2.38B | 6.56B | 7.23B | 6.46B | 8.17B |
| Net Income Ratio | 15.29% | 15.60% | 13.85% | 13.50% | 11.68% | 11.65% | 11.07% | 10.10% | 7.97% | 6.98% | 6.05% | 5.90% | 4.80% | 4.47% | 2.44% | 1.58% | 4.12% | 4.81% | 4.51% | 6.11% |
| EPS | 141.17 | 139.01 | 107.92 | 93.50 | 83.91 | 259.28 | 230.96 | 202.27 | 152.82 | 129.48 | 106.20 | 95.76 | 78.82 | 72.44 | 36.52 | 24.44 | 65.62 | 71.10 | 64.00 | 80.72 |
| EPS Diluted | 141.17 | 139.01 | 107.92 | 93.50 | 83.91 | 259.28 | 230.96 | 202.27 | 152.82 | 129.48 | 106.20 | 95.76 | 78.82 | 72.44 | 36.52 | 24.44 | 65.60 | 71.02 | 60.08 | 75.96 |
| Weighted Avg Shares Out | 240.77M | 244.40M | 247.31M | 249.23M | 251.94M | 84.98M | 86.22M | 86.95M | 88.93M | 90.39M | 91.69M | 91.73M | 92.85M | 95.07M | 95.84M | 97.44M | 99.97M | 101.65M | 99.72M | 100.29M |
| Weighted Avg Shares Out (Dil) | 240.77M | 244.40M | 247.31M | 249.23M | 251.94M | 84.98M | 86.22M | 86.95M | 88.93M | 90.39M | 91.69M | 91.73M | 92.85M | 95.07M | 95.84M | 97.44M | 99.98M | 101.76M | 107.46M | 107.52M |
Source: https://incomestatements.info
Category: Stock Reports